From the NYT article:
No one really knows whether preventive medicine will save money in the long run, let alone free up the billions of dollars a year needed to help pay for universal health insurance. In fact, studies have shown that preventive care — be it cancer screening, smoking cessation or plain old checkups — usually ends up costing money. It makes people healthier, but it’s not free.
As Dr. Mark R. Chassin, a former New York state health commissioner, says, preventive care “reduces costs, yes, for the individual who didn’t get sick.”
“But that savings is overwhelmed by the cost of continuously treating everybody else.”
The actual savings are also not [QUOTE]as large as might at first seem.
Even if you don’t develop diabetes, your lifetime medical costs won’t drop to zero. You might live longer and better and yet still ultimately run up almost as big a lifetime medical bill, because you’ll eventually have other problems. That would be an undeniably better outcome, but it wouldn’t produce a financial windfall for society.[/QUOTE]
No one except the NYT is asserting that preventative care will eliminate the cost of healthcare. What I’m saying is that it’s still cheaper to prevent illnesses than it is to treat them. Also the NYT article assumes that doctors will be doing the preventative care, something that I don’t find to be true at Kaiser Permanente. None of the preventative care that I get is done by doctors; that’s one of the benefits in fact that nurses and physician assistants can do this kind of stuff. Unless you are going to a very small clinic, there’s no reason for doctors to be doing preventative care in any insurance coverage.
From the New England Journal article:
Studies have concluded that preventing illness can in some cases save money but in other cases can add to health care costs. For example, screening costs will exceed the savings from avoided treatment in cases in which only a very small fraction of the population would have become ill in the absence of preventive measures. Preventive measures that do not save money may or may not represent cost-effective care (i.e., good value for the resources expended). Whether any preventive measure saves money or is a reasonable investment despite adding to costs depends entirely on the particular intervention and the specific population in question. For example, drugs used to treat high cholesterol yield much greater value for the money if the targeted population is at high risk for coronary heart disease, and the efficiency of cancer screening can depend heavily on both the frequency of the screening and the level of cancer risk in the screened population.
There is no question that a lot of attention needs to be paid to preventative care through screening. For example, men can get breast cancer, but the percentage of men who get breast cancer is not great enough to justify screening them. But some men may demand the screening anyway, and then you have a problem that can’t easily be solved through quantitative analysis. And this is the thicket that healthcare, insurance companies and politicians are going to have to continually navigate.
I answered your CBO assertions in my previous post.